SIGYN THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $474.79K.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $232.94K, a 17.64% increase year-over-year.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $198.00K.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $172.27K.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $707.73K, a 53.44% decline from fiscal 2023.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $1.52M, a 946.97% increase from fiscal 2022.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $145.20K.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $396.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $707.73K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $474.79K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $232.94K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $1.52M 10-K · filed 2025-04-15 | |
| 2023-06-30 | $198.00K 10-Q · filed 2024-11-19 | |
| 2022-12-31 | $145.20K 10-K · filed 2024-02-20 | |
| 2020-12-31 | $396.00K 10-K · filed 2021-04-06 | |
| 2020-03-31 | $172.27K 10-Q · filed 2021-11-12 |